SLC6A13 and Alzheimer disease: Of particular interest from the darkgray module is the gene Slc6a13, as this gene, a GABA transporter, has been identified as a potential blood biomarker in AD (Long et al., 2016), suggesting this gene (in addition to Itgb2) may have translational relevance to human disease.